Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

IndexRUT P/E14.02 EPS (ttm)6.79 Insider Own2.80% Shs Outstand34.65M Perf Week-5.26%
Market Cap3.28B Forward P/E10.51 EPS next Y9.05 Insider Trans-5.50% Shs Float33.54M Perf Month-17.99%
Enterprise Value3.94B PEG0.63 EPS next Q1.80 Inst Own101.02% Short Float4.45% Perf Quarter-0.02%
Income252.49M P/S1.74 EPS this Y18.99% Inst Trans-1.01% Short Ratio2.84 Perf Half Y-25.06%
Sales1.89B P/B2.39 EPS next Y14.07% ROA9.46% Short Interest1.49M Perf YTD-8.02%
Book/sh39.79 P/C45.34 EPS next 5Y16.62% ROE17.92% 52W High156.26 -39.10% Perf Year-10.50%
Cash/sh2.10 P/FCF8.92 EPS past 3/5Y- 10.18% ROIC12.17% 52W Low86.26 10.33% Perf 3Y137.27%
Dividend Est.- EV/EBITDA8.54 Sales past 3/5Y8.97% 11.19% Gross Margin60.28% Volatility3.93% 4.73% Perf 5Y133.26%
Dividend TTM- EV/Sales2.09 EPS Y/Y TTM26.43% Oper. Margin19.89% ATR (14)4.81 Perf 10Y462.47%
Dividend Ex-DateNov 30, 2016 Quick Ratio0.68 Sales Y/Y TTM11.92% Profit Margin13.37% RSI (14)31.94 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio0.68 EPS Q/Q6.43% SMA20-13.65% Beta0.72 Target Price161.00
Payout0.00% Debt/Eq0.53 Sales Q/Q12.43% SMA50-9.55% Rel Volume0.72 Prev Close100.84
Employees10371 LT Debt/Eq0.50 EarningsJan 28 AMC SMA200-21.01% Avg Volume525.69K Price95.17
IPOJun 21, 1991 Option/ShortYes / Yes EPS/Sales Surpr.11.09% 3.00% Trades Volume381,941 Change-5.62%
Date Action Analyst Rating Change Price Target Change
Apr-23-25Initiated Jefferies Buy $135
Oct-27-23Upgrade Robert W. Baird Neutral → Outperform $47 → $55
Jul-07-23Upgrade BMO Capital Markets Market Perform → Outperform $44
Aug-23-21Resumed BMO Capital Markets Market Perform $40
Sep-12-19Initiated Sidoti Buy
Feb-11-26 09:27AM
Feb-10-26 11:34PM
11:00PM
11:40AM
Feb-09-26 11:40AM
09:23AM Loading…
Feb-06-26 09:23AM
Feb-05-26 09:40AM
05:30AM
Feb-04-26 10:27AM
12:36AM
Feb-03-26 10:33AM
Feb-01-26 11:35PM
Jan-30-26 12:45PM
12:00PM
09:55AM
09:40AM Loading…
09:40AM
09:40AM
Jan-29-26 12:25PM
12:34AM
12:01AM
Jan-28-26 08:40PM
06:05PM
05:42PM
05:12PM
04:15PM
Jan-26-26 10:06PM
Jan-16-26 08:00AM
Jan-13-26 07:04AM
Jan-08-26 09:31AM
Jan-07-26 03:00PM
12:36PM Loading…
12:36PM
11:40AM
09:40AM
Jan-05-26 08:00AM
Dec-31-25 09:40AM
Dec-30-25 09:45AM
Dec-22-25 11:40AM
09:40AM
Dec-17-25 12:00PM
Dec-15-25 08:29AM
08:00AM
Dec-11-25 09:45AM
Dec-09-25 09:40AM
Dec-05-25 11:40AM
09:40AM
Dec-04-25 09:54AM
Dec-03-25 09:55AM
09:51AM
Dec-02-25 11:39PM
Dec-01-25 11:30AM
Nov-30-25 10:37PM
Nov-28-25 12:45PM
Nov-25-25 09:45AM
Nov-20-25 09:40AM
Nov-19-25 11:40AM
09:41AM
09:35AM
Nov-18-25 11:35PM
Nov-12-25 12:45PM
Nov-11-25 01:22PM
Nov-06-25 12:36AM
Nov-05-25 06:00AM
Nov-04-25 09:45AM
Nov-03-25 11:40AM
Oct-31-25 01:01PM
08:50AM
Oct-30-25 11:04PM
06:10PM
05:37PM
05:10PM
04:15PM
Oct-28-25 11:05PM
Oct-27-25 10:17AM
08:34AM
Oct-23-25 08:00AM
Oct-17-25 03:29PM
Oct-13-25 09:40AM
12:03AM
Oct-10-25 11:40AM
Oct-09-25 04:02PM
Oct-07-25 02:40PM
Oct-06-25 01:06PM
Oct-04-25 12:31AM
Oct-03-25 09:40AM
Oct-02-25 08:30AM
Sep-25-25 09:40AM
Sep-24-25 10:02AM
01:00AM
Sep-10-25 12:00PM
05:14AM
Sep-08-25 04:59PM
04:29PM
08:30AM
Sep-04-25 11:36PM
Sep-03-25 09:59AM
Sep-02-25 11:44AM
Sep-01-25 09:50AM
Aug-28-25 09:21AM
Aug-26-25 09:40AM
Aug-21-25 08:30AM
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Phelan Kenneth JDirectorNov 05 '25Buy98.2950849,93118,783Nov 05 04:12 PM
MALAFRONTE MICHAEL WLead Independent DirectorNov 04 '25Buy91.851,00091,850100,445Nov 04 04:43 PM
WARDELL LISA WDirectorAug 28 '25Sale132.3825,4773,372,66343,451Aug 29 04:20 PM
LISA W. WARDELLDirectorAug 28 '25Proposed Sale132.3825,4773,372,663Aug 28 04:15 PM
WARDELL LISA WDirectorAug 27 '25Sale135.2218,3922,486,88968,928Aug 27 05:47 PM
Gangadharan ManjunathVP, Chief Accounting OfficerAug 27 '25Sale135.67944128,0724,901Aug 27 05:39 PM
MANJUNATH GANGADHARANOfficerAug 27 '25Proposed Sale135.90944128,290Aug 27 04:25 PM
LISA W. WARDELLDirectorAug 27 '25Proposed Sale135.2218,3922,486,889Aug 27 04:11 PM
WARDELL LISA WDirectorAug 21 '25Sale132.9012,9001,714,46592,477Aug 25 04:11 PM
Lisa W. WardellDirectorAug 21 '25Proposed Sale132.8912,9001,714,281Aug 21 04:36 PM
BURKE WILLIAM WDirectorJun 05 '25Sale128.352,291294,0489,368Jun 06 04:32 PM
BURKE WILLIAM WDirectorJun 05 '25Proposed Sale128.132,291293,548Jun 05 04:40 PM
Gangadharan ManjunathVP, Chief Accounting OfficerMay 21 '25Sale131.66966127,1844,300May 22 04:20 PM
MANJUNATH GANGADHARANOfficerMay 21 '25Proposed Sale133.28966128,748May 21 04:19 PM
BLAKE CORBETT SIMPSONTerminated officer within 90daMay 15 '25Proposed Sale130.2562080,756May 15 04:33 PM
MALAFRONTE MICHAEL WLead Independent DirectorMar 07 '25Buy87.211,00087,21099,445Mar 07 04:18 PM
Hrinak Donna JDirectorFeb 21 '25Sale97.9291589,5977,117Feb 24 04:15 PM
Hrinak Donna JDirectorFeb 21 '25Proposed Sale105.0991596,161Feb 21 10:22 AM
Hrinak Donna JDirectorFeb 14 '25Sale103.264,812496,8728,032Feb 18 04:27 PM
DONNA JEAN HRINAKDirectorFeb 14 '25Proposed Sale103.264,812496,872Feb 14 04:07 PM
Last Close
Feb 11  •  04:00PM ET
27.62
Dollar change
-0.05
Percentage change
-0.18
%
TCMD Tactile Systems Technology Inc daily Stock Chart
IndexRUT P/E35.66 EPS (ttm)0.77 Insider Own4.00% Shs Outstand22.34M Perf Week-0.04%
Market Cap616.91M Forward P/E27.08 EPS next Y1.02 Insider Trans-1.42% Shs Float21.44M Perf Month-7.53%
Enterprise Value567.67M PEG1.20 EPS next Q0.44 Inst Own94.25% Short Float8.53% Perf Quarter10.97%
Income18.17M P/S1.98 EPS this Y13.74% Inst Trans-2.42% Short Ratio5.10 Perf Half Y119.73%
Sales311.51M P/B3.01 EPS next Y28.12% ROA6.64% Short Interest1.83M Perf YTD-4.76%
Book/sh9.18 P/C9.35 EPS next 5Y22.58% ROE8.80% 52W High31.38 -11.98% Perf Year63.92%
Cash/sh2.95 P/FCF15.61 EPS past 3/5Y- 4.69% ROIC8.31% 52W Low8.61 220.80% Perf 3Y127.89%
Dividend Est.- EV/EBITDA19.08 Sales past 3/5Y12.09% 9.11% Gross Margin74.16% Volatility3.89% 3.89% Perf 5Y-55.15%
Dividend TTM- EV/Sales1.82 EPS Y/Y TTM21.00% Oper. Margin7.39% ATR (14)1.12 Perf 10Y-
Dividend Ex-Date- Quick Ratio3.20 Sales Y/Y TTM9.28% Profit Margin5.83% RSI (14)42.13 Recom1.40
Dividend Gr. 3/5Y- - Current Ratio3.61 EPS Q/Q71.58% SMA20-4.27% Beta0.98 Target Price29.75
Payout0.00% Debt/Eq0.08 Sales Q/Q17.32% SMA50-4.10% Rel Volume0.87 Prev Close27.67
Employees1037 LT Debt/Eq0.07 EarningsFeb 17 AMC SMA20059.15% Avg Volume359.05K Price27.62
IPOJul 28, 2016 Option/ShortYes / Yes EPS/Sales Surpr.114.41% 8.14% Trades Volume323,812 Change-0.18%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Upgrade Piper Sandler Neutral → Overweight $35
Nov-04-25Upgrade BTIG Research Neutral → Buy $28
Oct-03-25Initiated Lake Street Buy $23.50
May-06-25Downgrade Piper Sandler Overweight → Neutral $14
Feb-19-25Downgrade B. Riley Securities Buy → Neutral $23 → $18
Nov-05-24Downgrade Oppenheimer Outperform → Perform
Nov-05-24Downgrade BTIG Research Buy → Neutral
Sep-26-24Initiated B. Riley Securities Buy $23
Nov-13-20Upgrade Oppenheimer Perform → Outperform $55
Oct-22-19Initiated Oppenheimer Perform
Feb-03-26 04:05PM
Jan-05-26 12:51PM
Dec-16-25 09:40AM
Nov-28-25 12:00PM
Nov-27-25 09:40AM
04:31AM Loading…
Nov-20-25 04:31AM
Nov-19-25 10:00AM
09:27AM
05:01AM
Nov-18-25 04:05PM
Nov-13-25 12:00PM
Nov-11-25 06:27AM
Nov-05-25 09:40AM
Nov-04-25 12:04AM
Nov-03-25 05:50PM
04:48PM Loading…
04:48PM
04:05PM
Oct-31-25 09:31AM
Oct-30-25 05:40PM
Oct-29-25 05:55PM
Oct-28-25 04:05PM
Oct-20-25 04:05PM
Sep-24-25 09:40AM
Sep-08-25 04:59PM
04:34PM
Aug-22-25 09:40AM
Aug-06-25 09:40AM
09:35AM
09:30AM
Aug-05-25 03:05AM
05:35PM Loading…
Aug-04-25 05:35PM
04:35PM
04:05PM
Jul-30-25 05:15PM
Jul-21-25 04:05PM
Jul-14-25 07:23AM
Jun-03-25 08:00AM
May-20-25 04:05PM
May-06-25 12:09PM
03:08AM
May-05-25 05:30PM
04:27PM
04:05PM
May-02-25 09:33AM
Apr-30-25 05:50PM
Apr-21-25 04:05PM
Apr-07-25 12:58PM
Mar-05-25 04:05PM
Feb-19-25 11:23AM
02:06AM
Feb-18-25 07:20PM
06:17PM
04:05PM
02:52AM
Feb-05-25 04:05PM
Feb-04-25 08:00AM
Jan-13-25 08:00AM
Jan-01-25 09:40AM
Dec-16-24 03:34PM
Nov-28-24 09:40AM
Nov-26-24 09:15AM
Nov-19-24 04:05PM
Nov-18-24 07:09AM
Nov-12-24 09:40AM
Nov-07-24 09:55AM
Nov-04-24 05:30PM
04:30PM
04:05PM
Nov-01-24 09:07AM
Oct-28-24 10:01AM
Oct-21-24 04:05PM
Oct-04-24 06:05AM
Oct-02-24 08:00AM
Sep-25-24 12:02PM
08:00AM
Sep-20-24 08:38AM
Sep-16-24 08:00AM
Aug-07-24 09:55AM
09:40AM
09:35AM
09:30AM
Aug-06-24 01:59PM
Aug-05-24 06:15PM
05:11PM
04:05PM
Jul-22-24 04:05PM
Jun-27-24 02:03PM
May-21-24 04:05PM
May-08-24 09:40AM
May-07-24 10:48AM
07:04AM
03:13AM
May-06-24 05:50PM
05:47PM
04:47PM
04:05PM
May-02-24 05:45PM
09:00AM
Apr-26-24 05:45PM
Apr-24-24 07:09AM
Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema solutions and offers Flexitouch Plus and Entre Plus systems products. The company was founded on January 30, 1995 and is headquartered in Minneapolis, MN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burns KristieSr. VP Mktg & Clinical AffairsJan 02 '26Sale28.855,139148,26072,401Jan 06 04:53 PM
Burns KristieOfficerJan 02 '26Proposed Sale28.855,139148,260Jan 02 10:35 AM
Dodd Sheri LouiseChief Executive OfficerAug 08 '25Sale12.367,76295,907173,479Aug 12 06:03 PM
Dodd Sheri LouiseOfficerAug 08 '25Proposed Sale12.367,76295,906Aug 08 03:40 PM
Birkemeyer Elaine M.Chief Financial OfficerMay 12 '25Sale9.942,92129,03799,111May 14 05:26 PM
Birkemeyer Elaine M.OfficerMay 12 '25Proposed Sale9.942,92129,037May 12 05:25 PM
Dodd Sheri LouiseChief Executive OfficerMay 08 '25Sale9.833,14930,955181,241May 12 04:34 PM
BURKE WILLIAM WDirectorMay 08 '25Sale9.673,30031,91148,520May 09 04:28 PM
Dodd Sheri LouiseDirectorMay 08 '25Proposed Sale9.833,14930,955May 08 07:17 PM
BURKE WILLIAM WDirectorMay 08 '25Proposed Sale9.673,30031,911May 08 04:46 PM
Ferstler Sherri LeeOfficerApr 03 '25Proposed Sale13.142,35530,945Apr 03 05:30 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 25 '25Sale14.512,06629,980102,032Feb 27 04:29 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 25 '25Sale14.406,46893,16077,540Feb 27 04:28 PM
REUVERS DANIEL L.DirectorFeb 25 '25Sale14.1828,338401,850214,604Feb 27 04:27 PM
REUVERS DANIEL L.OfficerFeb 25 '25Proposed Sale14.1828,338401,851Feb 25 07:35 PM
Burns KristieOfficerFeb 25 '25Proposed Sale14.406,46893,160Feb 25 07:15 PM
Birkemeyer Elaine M.OfficerFeb 25 '25Proposed Sale14.512,06629,980Feb 25 06:54 PM
REUVERS DANIEL L.DirectorFeb 24 '25Sale14.5510,938159,147242,942Feb 24 06:24 PM
Burns KristieSr. VP Mktg & Clinical AffairsFeb 24 '25Sale14.654,83070,75384,008Feb 24 06:23 PM
Birkemeyer Elaine M.Chief Financial OfficerFeb 24 '25Sale14.703,77855,538104,098Feb 24 06:22 PM
REUVERS DANIEL L.OfficerFeb 24 '25Proposed Sale14.5510,938159,147Feb 24 05:23 PM
Burns KristieOfficerFeb 24 '25Proposed Sale14.654,83070,753Feb 24 05:12 PM
Ferstler Sherri LeeOfficerFeb 24 '25Proposed Sale14.792,20932,660Feb 24 04:58 PM
Birkemeyer Elaine M.OfficerFeb 24 '25Proposed Sale14.703,77855,538Feb 24 04:55 PM